nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanfacine—CYP2C19—coronary artery disease	0.238	1	CbGaD
Guanfacine—CYP2C9—Fenofibrate—coronary artery disease	0.0294	0.0589	CbGbCtD
Guanfacine—CYP2C19—Gemfibrozil—coronary artery disease	0.0282	0.0566	CbGbCtD
Guanfacine—CYP2C19—Clopidogrel—coronary artery disease	0.0245	0.0491	CbGbCtD
Guanfacine—CYP2C9—Gemfibrozil—coronary artery disease	0.0235	0.0471	CbGbCtD
Guanfacine—CYP2C19—Telmisartan—coronary artery disease	0.0214	0.0429	CbGbCtD
Guanfacine—CYP2C9—Clopidogrel—coronary artery disease	0.0204	0.0408	CbGbCtD
Guanfacine—CYP3A4—Ticagrelor—coronary artery disease	0.0192	0.0384	CbGbCtD
Guanfacine—CYP2C9—Pitavastatin—coronary artery disease	0.0178	0.0357	CbGbCtD
Guanfacine—CYP2C9—Valsartan—coronary artery disease	0.0173	0.0347	CbGbCtD
Guanfacine—CYP2C19—Timolol—coronary artery disease	0.0173	0.0346	CbGbCtD
Guanfacine—CYP3A4—Fenofibrate—coronary artery disease	0.0171	0.0342	CbGbCtD
Guanfacine—CYP2C19—Rosuvastatin—coronary artery disease	0.0158	0.0316	CbGbCtD
Guanfacine—CYP2C19—Acetylsalicylic acid—coronary artery disease	0.0154	0.0308	CbGbCtD
Guanfacine—CYP2C19—Simvastatin—coronary artery disease	0.0147	0.0294	CbGbCtD
Guanfacine—CYP2C19—Lovastatin—coronary artery disease	0.0144	0.0288	CbGbCtD
Guanfacine—CYP3A4—Gemfibrozil—coronary artery disease	0.0137	0.0274	CbGbCtD
Guanfacine—CYP2C9—Rosuvastatin—coronary artery disease	0.0131	0.0263	CbGbCtD
Guanfacine—CYP2C19—Atorvastatin—coronary artery disease	0.0131	0.0262	CbGbCtD
Guanfacine—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.0128	0.0256	CbGbCtD
Guanfacine—CYP2C9—Simvastatin—coronary artery disease	0.0122	0.0245	CbGbCtD
Guanfacine—CYP2C19—Losartan—coronary artery disease	0.012	0.024	CbGbCtD
Guanfacine—CYP2C9—Lovastatin—coronary artery disease	0.0119	0.0239	CbGbCtD
Guanfacine—CYP2C9—Pravastatin—coronary artery disease	0.0119	0.0239	CbGbCtD
Guanfacine—CYP3A4—Clopidogrel—coronary artery disease	0.0118	0.0237	CbGbCtD
Guanfacine—CYP3A4—Eplerenone—coronary artery disease	0.011	0.0221	CbGbCtD
Guanfacine—CYP2C9—Atorvastatin—coronary artery disease	0.0109	0.0218	CbGbCtD
Guanfacine—CYP2C9—Losartan—coronary artery disease	0.00994	0.0199	CbGbCtD
Guanfacine—CYP3A4—Enalapril—coronary artery disease	0.00981	0.0197	CbGbCtD
Guanfacine—CYP3A4—Ezetimibe—coronary artery disease	0.00763	0.0153	CbGbCtD
Guanfacine—CYP3A4—Rosuvastatin—coronary artery disease	0.00763	0.0153	CbGbCtD
Guanfacine—CYP3A4—Simvastatin—coronary artery disease	0.00709	0.0142	CbGbCtD
Guanfacine—CYP3A4—Pravastatin—coronary artery disease	0.00694	0.0139	CbGbCtD
Guanfacine—CYP3A4—Lovastatin—coronary artery disease	0.00694	0.0139	CbGbCtD
Guanfacine—CYP3A4—Atorvastatin—coronary artery disease	0.00632	0.0127	CbGbCtD
Guanfacine—CYP3A4—Losartan—coronary artery disease	0.00578	0.0116	CbGbCtD
Guanfacine—CYP2C9—cardial valve—coronary artery disease	0.00259	0.544	CbGeAlD
Guanfacine—Diclofenac—PLA2G2A—coronary artery disease	0.00181	0.625	CrCbGaD
Guanfacine—NISCH—myocardium—coronary artery disease	0.000544	0.114	CbGeAlD
Guanfacine—Diclofenac—CXCL8—coronary artery disease	0.000537	0.186	CrCbGaD
Guanfacine—NISCH—heart—coronary artery disease	0.00038	0.0798	CbGeAlD
Guanfacine—NISCH—blood—coronary artery disease	0.000283	0.0596	CbGeAlD
Guanfacine—Diclofenac—CYP2C19—coronary artery disease	0.000251	0.0869	CrCbGaD
Guanfacine—Diclofenac—PTGS2—coronary artery disease	0.000157	0.0541	CrCbGaD
Guanfacine—CYP2C9—heart—coronary artery disease	0.000143	0.03	CbGeAlD
Guanfacine—Diclofenac—ALB—coronary artery disease	0.000139	0.0482	CrCbGaD
Guanfacine—ADRA2A—heart—coronary artery disease	0.000138	0.0291	CbGeAlD
Guanfacine—CYP2C19—blood—coronary artery disease	0.000138	0.0289	CbGeAlD
Guanfacine—CYP2C9—cardiovascular system—coronary artery disease	0.000135	0.0283	CbGeAlD
Guanfacine—ADRA2A—cardiac atrium—coronary artery disease	0.000118	0.0249	CbGeAlD
Guanfacine—CYP2C9—blood—coronary artery disease	0.000107	0.0224	CbGeAlD
Guanfacine—ADRA2A—blood—coronary artery disease	0.000103	0.0217	CbGeAlD
Guanfacine—Dizziness—Eplerenone—coronary artery disease	9.14e-05	0.000473	CcSEcCtD
Guanfacine—Rash—Clopidogrel—coronary artery disease	9.14e-05	0.000473	CcSEcCtD
Guanfacine—Dermatitis—Clopidogrel—coronary artery disease	9.13e-05	0.000473	CcSEcCtD
Guanfacine—Asthenia—Valsartan—coronary artery disease	9.12e-05	0.000472	CcSEcCtD
Guanfacine—Hypertension—Timolol—coronary artery disease	9.12e-05	0.000472	CcSEcCtD
Guanfacine—Constipation—Furosemide—coronary artery disease	9.11e-05	0.000472	CcSEcCtD
Guanfacine—Hypersensitivity—Niacin—coronary artery disease	9.11e-05	0.000472	CcSEcCtD
Guanfacine—Ill-defined disorder—Lisinopril—coronary artery disease	9.09e-05	0.000471	CcSEcCtD
Guanfacine—Discomfort—Ramipril—coronary artery disease	9.09e-05	0.000471	CcSEcCtD
Guanfacine—Asthenia—Olmesartan—coronary artery disease	9.08e-05	0.00047	CcSEcCtD
Guanfacine—Headache—Clopidogrel—coronary artery disease	9.08e-05	0.00047	CcSEcCtD
Guanfacine—Rash—Lovastatin—coronary artery disease	9.08e-05	0.00047	CcSEcCtD
Guanfacine—Dermatitis—Lovastatin—coronary artery disease	9.07e-05	0.00047	CcSEcCtD
Guanfacine—Dyspepsia—Losartan—coronary artery disease	9.05e-05	0.000469	CcSEcCtD
Guanfacine—Feeling abnormal—Perindopril—coronary artery disease	9.03e-05	0.000468	CcSEcCtD
Guanfacine—Headache—Lovastatin—coronary artery disease	9.02e-05	0.000467	CcSEcCtD
Guanfacine—Pruritus—Valsartan—coronary artery disease	9e-05	0.000466	CcSEcCtD
Guanfacine—Dry mouth—Ramipril—coronary artery disease	9e-05	0.000466	CcSEcCtD
Guanfacine—Myalgia—Timolol—coronary artery disease	8.99e-05	0.000466	CcSEcCtD
Guanfacine—Arthralgia—Timolol—coronary artery disease	8.99e-05	0.000466	CcSEcCtD
Guanfacine—Chest pain—Timolol—coronary artery disease	8.99e-05	0.000466	CcSEcCtD
Guanfacine—Vomiting—Ezetimibe—coronary artery disease	8.98e-05	0.000465	CcSEcCtD
Guanfacine—Hypersensitivity—Pravastatin—coronary artery disease	8.97e-05	0.000464	CcSEcCtD
Guanfacine—Gastrointestinal pain—Perindopril—coronary artery disease	8.97e-05	0.000464	CcSEcCtD
Guanfacine—Anxiety—Timolol—coronary artery disease	8.96e-05	0.000464	CcSEcCtD
Guanfacine—Pruritus—Olmesartan—coronary artery disease	8.95e-05	0.000464	CcSEcCtD
Guanfacine—Decreased appetite—Losartan—coronary artery disease	8.94e-05	0.000463	CcSEcCtD
Guanfacine—Abdominal pain—Captopril—coronary artery disease	8.93e-05	0.000462	CcSEcCtD
Guanfacine—Dizziness—Simvastatin—coronary artery disease	8.9e-05	0.000461	CcSEcCtD
Guanfacine—Rash—Ezetimibe—coronary artery disease	8.9e-05	0.000461	CcSEcCtD
Guanfacine—Dermatitis—Ezetimibe—coronary artery disease	8.89e-05	0.000461	CcSEcCtD
Guanfacine—Confusional state—Ramipril—coronary artery disease	8.89e-05	0.00046	CcSEcCtD
Guanfacine—Discomfort—Timolol—coronary artery disease	8.88e-05	0.00046	CcSEcCtD
Guanfacine—Asthenia—Niacin—coronary artery disease	8.87e-05	0.000459	CcSEcCtD
Guanfacine—Fatigue—Losartan—coronary artery disease	8.87e-05	0.000459	CcSEcCtD
Guanfacine—Headache—Ezetimibe—coronary artery disease	8.84e-05	0.000458	CcSEcCtD
Guanfacine—Malaise—Lisinopril—coronary artery disease	8.84e-05	0.000458	CcSEcCtD
Guanfacine—Oedema—Ramipril—coronary artery disease	8.82e-05	0.000457	CcSEcCtD
Guanfacine—Vertigo—Lisinopril—coronary artery disease	8.8e-05	0.000456	CcSEcCtD
Guanfacine—Dry mouth—Timolol—coronary artery disease	8.79e-05	0.000455	CcSEcCtD
Guanfacine—Constipation—Losartan—coronary artery disease	8.79e-05	0.000455	CcSEcCtD
Guanfacine—Syncope—Lisinopril—coronary artery disease	8.79e-05	0.000455	CcSEcCtD
Guanfacine—Vomiting—Eplerenone—coronary artery disease	8.79e-05	0.000455	CcSEcCtD
Guanfacine—Feeling abnormal—Furosemide—coronary artery disease	8.78e-05	0.000455	CcSEcCtD
Guanfacine—Nausea—Fenofibrate—coronary artery disease	8.76e-05	0.000453	CcSEcCtD
Guanfacine—Pruritus—Niacin—coronary artery disease	8.75e-05	0.000453	CcSEcCtD
Guanfacine—Asthenia—Pravastatin—coronary artery disease	8.73e-05	0.000452	CcSEcCtD
Guanfacine—Gastrointestinal pain—Furosemide—coronary artery disease	8.72e-05	0.000451	CcSEcCtD
Guanfacine—Rash—Eplerenone—coronary artery disease	8.71e-05	0.000451	CcSEcCtD
Guanfacine—Hypersensitivity—Trandolapril—coronary artery disease	8.71e-05	0.000451	CcSEcCtD
Guanfacine—Dermatitis—Eplerenone—coronary artery disease	8.71e-05	0.000451	CcSEcCtD
Guanfacine—Diarrhoea—Valsartan—coronary artery disease	8.7e-05	0.00045	CcSEcCtD
Guanfacine—Confusional state—Timolol—coronary artery disease	8.69e-05	0.00045	CcSEcCtD
Guanfacine—Shock—Ramipril—coronary artery disease	8.68e-05	0.000449	CcSEcCtD
Guanfacine—Hypersensitivity—Enalapril—coronary artery disease	8.67e-05	0.000449	CcSEcCtD
Guanfacine—Abdominal pain—Perindopril—coronary artery disease	8.67e-05	0.000449	CcSEcCtD
Guanfacine—Palpitations—Lisinopril—coronary artery disease	8.66e-05	0.000448	CcSEcCtD
Guanfacine—Diarrhoea—Olmesartan—coronary artery disease	8.66e-05	0.000448	CcSEcCtD
Guanfacine—Headache—Eplerenone—coronary artery disease	8.66e-05	0.000448	CcSEcCtD
Guanfacine—Oedema—Timolol—coronary artery disease	8.62e-05	0.000446	CcSEcCtD
Guanfacine—Pruritus—Pravastatin—coronary artery disease	8.61e-05	0.000446	CcSEcCtD
Guanfacine—Loss of consciousness—Lisinopril—coronary artery disease	8.61e-05	0.000446	CcSEcCtD
Guanfacine—Nausea—Clopidogrel—coronary artery disease	8.61e-05	0.000446	CcSEcCtD
Guanfacine—Tachycardia—Ramipril—coronary artery disease	8.61e-05	0.000446	CcSEcCtD
Guanfacine—Vomiting—Simvastatin—coronary artery disease	8.56e-05	0.000443	CcSEcCtD
Guanfacine—Hypersensitivity—Telmisartan—coronary artery disease	8.56e-05	0.000443	CcSEcCtD
Guanfacine—Nausea—Lovastatin—coronary artery disease	8.55e-05	0.000443	CcSEcCtD
Guanfacine—Hyperhidrosis—Ramipril—coronary artery disease	8.52e-05	0.000441	CcSEcCtD
Guanfacine—Rash—Simvastatin—coronary artery disease	8.49e-05	0.00044	CcSEcCtD
Guanfacine—Dermatitis—Simvastatin—coronary artery disease	8.48e-05	0.000439	CcSEcCtD
Guanfacine—Asthenia—Trandolapril—coronary artery disease	8.48e-05	0.000439	CcSEcCtD
Guanfacine—Shock—Timolol—coronary artery disease	8.48e-05	0.000439	CcSEcCtD
Guanfacine—Feeling abnormal—Losartan—coronary artery disease	8.47e-05	0.000439	CcSEcCtD
Guanfacine—Diarrhoea—Niacin—coronary artery disease	8.46e-05	0.000438	CcSEcCtD
Guanfacine—Asthenia—Enalapril—coronary artery disease	8.45e-05	0.000437	CcSEcCtD
Guanfacine—Headache—Simvastatin—coronary artery disease	8.43e-05	0.000437	CcSEcCtD
Guanfacine—Abdominal pain—Furosemide—coronary artery disease	8.43e-05	0.000436	CcSEcCtD
Guanfacine—Gastrointestinal pain—Losartan—coronary artery disease	8.41e-05	0.000435	CcSEcCtD
Guanfacine—Dizziness—Valsartan—coronary artery disease	8.41e-05	0.000435	CcSEcCtD
Guanfacine—Nausea—Ezetimibe—coronary artery disease	8.39e-05	0.000434	CcSEcCtD
Guanfacine—Dizziness—Olmesartan—coronary artery disease	8.37e-05	0.000433	CcSEcCtD
Guanfacine—Pruritus—Trandolapril—coronary artery disease	8.36e-05	0.000433	CcSEcCtD
Guanfacine—Myalgia—Lisinopril—coronary artery disease	8.34e-05	0.000432	CcSEcCtD
Guanfacine—Arthralgia—Lisinopril—coronary artery disease	8.34e-05	0.000432	CcSEcCtD
Guanfacine—Chest pain—Lisinopril—coronary artery disease	8.34e-05	0.000432	CcSEcCtD
Guanfacine—Hyperhidrosis—Timolol—coronary artery disease	8.33e-05	0.000432	CcSEcCtD
Guanfacine—Asthenia—Telmisartan—coronary artery disease	8.33e-05	0.000431	CcSEcCtD
Guanfacine—Pruritus—Enalapril—coronary artery disease	8.33e-05	0.000431	CcSEcCtD
Guanfacine—Diarrhoea—Pravastatin—coronary artery disease	8.33e-05	0.000431	CcSEcCtD
Guanfacine—Anxiety—Lisinopril—coronary artery disease	8.31e-05	0.00043	CcSEcCtD
Guanfacine—Discomfort—Lisinopril—coronary artery disease	8.24e-05	0.000427	CcSEcCtD
Guanfacine—Hypotension—Ramipril—coronary artery disease	8.24e-05	0.000427	CcSEcCtD
Guanfacine—Pruritus—Telmisartan—coronary artery disease	8.22e-05	0.000425	CcSEcCtD
Guanfacine—Nausea—Eplerenone—coronary artery disease	8.21e-05	0.000425	CcSEcCtD
Guanfacine—Dizziness—Niacin—coronary artery disease	8.18e-05	0.000423	CcSEcCtD
Guanfacine—Dry mouth—Lisinopril—coronary artery disease	8.16e-05	0.000422	CcSEcCtD
Guanfacine—CYP3A4—blood—coronary artery disease	8.13e-05	0.0171	CbGeAlD
Guanfacine—Abdominal pain—Losartan—coronary artery disease	8.13e-05	0.000421	CcSEcCtD
Guanfacine—Asthenia—Captopril—coronary artery disease	8.1e-05	0.00042	CcSEcCtD
Guanfacine—Diarrhoea—Trandolapril—coronary artery disease	8.09e-05	0.000419	CcSEcCtD
Guanfacine—Vomiting—Valsartan—coronary artery disease	8.08e-05	0.000419	CcSEcCtD
Guanfacine—Confusional state—Lisinopril—coronary artery disease	8.06e-05	0.000418	CcSEcCtD
Guanfacine—Diarrhoea—Enalapril—coronary artery disease	8.06e-05	0.000417	CcSEcCtD
Guanfacine—Hypotension—Timolol—coronary artery disease	8.06e-05	0.000417	CcSEcCtD
Guanfacine—Dizziness—Pravastatin—coronary artery disease	8.05e-05	0.000417	CcSEcCtD
Guanfacine—Vomiting—Olmesartan—coronary artery disease	8.05e-05	0.000417	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Ramipril—coronary artery disease	8.03e-05	0.000416	CcSEcCtD
Guanfacine—Rash—Valsartan—coronary artery disease	8.02e-05	0.000415	CcSEcCtD
Guanfacine—Dermatitis—Valsartan—coronary artery disease	8.01e-05	0.000415	CcSEcCtD
Guanfacine—Nausea—Simvastatin—coronary artery disease	8e-05	0.000414	CcSEcCtD
Guanfacine—Oedema—Lisinopril—coronary artery disease	8e-05	0.000414	CcSEcCtD
Guanfacine—Pruritus—Captopril—coronary artery disease	7.99e-05	0.000414	CcSEcCtD
Guanfacine—Rash—Olmesartan—coronary artery disease	7.98e-05	0.000413	CcSEcCtD
Guanfacine—Insomnia—Ramipril—coronary artery disease	7.98e-05	0.000413	CcSEcCtD
Guanfacine—Dermatitis—Olmesartan—coronary artery disease	7.97e-05	0.000413	CcSEcCtD
Guanfacine—Headache—Valsartan—coronary artery disease	7.97e-05	0.000412	CcSEcCtD
Guanfacine—Diarrhoea—Telmisartan—coronary artery disease	7.95e-05	0.000411	CcSEcCtD
Guanfacine—Headache—Olmesartan—coronary artery disease	7.93e-05	0.00041	CcSEcCtD
Guanfacine—Paraesthesia—Ramipril—coronary artery disease	7.92e-05	0.00041	CcSEcCtD
Guanfacine—Shock—Lisinopril—coronary artery disease	7.87e-05	0.000407	CcSEcCtD
Guanfacine—Asthenia—Perindopril—coronary artery disease	7.87e-05	0.000407	CcSEcCtD
Guanfacine—Dyspnoea—Ramipril—coronary artery disease	7.86e-05	0.000407	CcSEcCtD
Guanfacine—Vomiting—Niacin—coronary artery disease	7.86e-05	0.000407	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Timolol—coronary artery disease	7.85e-05	0.000407	CcSEcCtD
Guanfacine—Hypersensitivity—Furosemide—coronary artery disease	7.85e-05	0.000407	CcSEcCtD
Guanfacine—Somnolence—Ramipril—coronary artery disease	7.84e-05	0.000406	CcSEcCtD
Guanfacine—Dizziness—Trandolapril—coronary artery disease	7.82e-05	0.000405	CcSEcCtD
Guanfacine—Tachycardia—Lisinopril—coronary artery disease	7.8e-05	0.000404	CcSEcCtD
Guanfacine—Insomnia—Timolol—coronary artery disease	7.8e-05	0.000404	CcSEcCtD
Guanfacine—Rash—Niacin—coronary artery disease	7.8e-05	0.000404	CcSEcCtD
Guanfacine—Dermatitis—Niacin—coronary artery disease	7.79e-05	0.000403	CcSEcCtD
Guanfacine—Dizziness—Enalapril—coronary artery disease	7.79e-05	0.000403	CcSEcCtD
Guanfacine—Dyspepsia—Ramipril—coronary artery disease	7.76e-05	0.000402	CcSEcCtD
Guanfacine—Pruritus—Perindopril—coronary artery disease	7.76e-05	0.000402	CcSEcCtD
Guanfacine—Headache—Niacin—coronary artery disease	7.75e-05	0.000401	CcSEcCtD
Guanfacine—Paraesthesia—Timolol—coronary artery disease	7.74e-05	0.000401	CcSEcCtD
Guanfacine—Vomiting—Pravastatin—coronary artery disease	7.74e-05	0.000401	CcSEcCtD
Guanfacine—Hyperhidrosis—Lisinopril—coronary artery disease	7.73e-05	0.0004	CcSEcCtD
Guanfacine—Diarrhoea—Captopril—coronary artery disease	7.73e-05	0.0004	CcSEcCtD
Guanfacine—Dyspnoea—Timolol—coronary artery disease	7.69e-05	0.000398	CcSEcCtD
Guanfacine—Dizziness—Telmisartan—coronary artery disease	7.68e-05	0.000398	CcSEcCtD
Guanfacine—Rash—Pravastatin—coronary artery disease	7.68e-05	0.000397	CcSEcCtD
Guanfacine—Dermatitis—Pravastatin—coronary artery disease	7.67e-05	0.000397	CcSEcCtD
Guanfacine—Decreased appetite—Ramipril—coronary artery disease	7.67e-05	0.000397	CcSEcCtD
Guanfacine—Somnolence—Timolol—coronary artery disease	7.66e-05	0.000397	CcSEcCtD
Guanfacine—Asthenia—Furosemide—coronary artery disease	7.65e-05	0.000396	CcSEcCtD
Guanfacine—Headache—Pravastatin—coronary artery disease	7.63e-05	0.000395	CcSEcCtD
Guanfacine—Fatigue—Ramipril—coronary artery disease	7.6e-05	0.000394	CcSEcCtD
Guanfacine—Dyspepsia—Timolol—coronary artery disease	7.59e-05	0.000393	CcSEcCtD
Guanfacine—Hypersensitivity—Losartan—coronary artery disease	7.58e-05	0.000392	CcSEcCtD
Guanfacine—Nausea—Valsartan—coronary artery disease	7.55e-05	0.000391	CcSEcCtD
Guanfacine—Pruritus—Furosemide—coronary artery disease	7.54e-05	0.00039	CcSEcCtD
Guanfacine—Constipation—Ramipril—coronary artery disease	7.54e-05	0.00039	CcSEcCtD
Guanfacine—Nausea—Olmesartan—coronary artery disease	7.52e-05	0.000389	CcSEcCtD
Guanfacine—Vomiting—Trandolapril—coronary artery disease	7.52e-05	0.000389	CcSEcCtD
Guanfacine—Diarrhoea—Perindopril—coronary artery disease	7.5e-05	0.000388	CcSEcCtD
Guanfacine—Decreased appetite—Timolol—coronary artery disease	7.49e-05	0.000388	CcSEcCtD
Guanfacine—Vomiting—Enalapril—coronary artery disease	7.49e-05	0.000388	CcSEcCtD
Guanfacine—Hypotension—Lisinopril—coronary artery disease	7.47e-05	0.000387	CcSEcCtD
Guanfacine—Dizziness—Captopril—coronary artery disease	7.47e-05	0.000387	CcSEcCtD
Guanfacine—Rash—Trandolapril—coronary artery disease	7.45e-05	0.000386	CcSEcCtD
Guanfacine—Dermatitis—Trandolapril—coronary artery disease	7.45e-05	0.000386	CcSEcCtD
Guanfacine—Fatigue—Timolol—coronary artery disease	7.43e-05	0.000385	CcSEcCtD
Guanfacine—Rash—Enalapril—coronary artery disease	7.42e-05	0.000384	CcSEcCtD
Guanfacine—Dermatitis—Enalapril—coronary artery disease	7.42e-05	0.000384	CcSEcCtD
Guanfacine—Headache—Trandolapril—coronary artery disease	7.41e-05	0.000383	CcSEcCtD
Guanfacine—Vomiting—Telmisartan—coronary artery disease	7.38e-05	0.000382	CcSEcCtD
Guanfacine—Asthenia—Losartan—coronary artery disease	7.38e-05	0.000382	CcSEcCtD
Guanfacine—Headache—Enalapril—coronary artery disease	7.38e-05	0.000382	CcSEcCtD
Guanfacine—Nausea—Niacin—coronary artery disease	7.34e-05	0.00038	CcSEcCtD
Guanfacine—Rash—Telmisartan—coronary artery disease	7.32e-05	0.000379	CcSEcCtD
Guanfacine—Dermatitis—Telmisartan—coronary artery disease	7.32e-05	0.000379	CcSEcCtD
Guanfacine—Diarrhoea—Furosemide—coronary artery disease	7.29e-05	0.000378	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Lisinopril—coronary artery disease	7.29e-05	0.000377	CcSEcCtD
Guanfacine—Pruritus—Losartan—coronary artery disease	7.28e-05	0.000377	CcSEcCtD
Guanfacine—Headache—Telmisartan—coronary artery disease	7.27e-05	0.000377	CcSEcCtD
Guanfacine—Feeling abnormal—Ramipril—coronary artery disease	7.27e-05	0.000376	CcSEcCtD
Guanfacine—Dizziness—Perindopril—coronary artery disease	7.25e-05	0.000375	CcSEcCtD
Guanfacine—Insomnia—Lisinopril—coronary artery disease	7.23e-05	0.000375	CcSEcCtD
Guanfacine—Nausea—Pravastatin—coronary artery disease	7.23e-05	0.000374	CcSEcCtD
Guanfacine—Gastrointestinal pain—Ramipril—coronary artery disease	7.21e-05	0.000373	CcSEcCtD
Guanfacine—Paraesthesia—Lisinopril—coronary artery disease	7.18e-05	0.000372	CcSEcCtD
Guanfacine—Vomiting—Captopril—coronary artery disease	7.18e-05	0.000372	CcSEcCtD
Guanfacine—Dyspnoea—Lisinopril—coronary artery disease	7.13e-05	0.000369	CcSEcCtD
Guanfacine—Rash—Captopril—coronary artery disease	7.12e-05	0.000369	CcSEcCtD
Guanfacine—Dermatitis—Captopril—coronary artery disease	7.11e-05	0.000368	CcSEcCtD
Guanfacine—Somnolence—Lisinopril—coronary artery disease	7.11e-05	0.000368	CcSEcCtD
Guanfacine—Feeling abnormal—Timolol—coronary artery disease	7.1e-05	0.000368	CcSEcCtD
Guanfacine—Headache—Captopril—coronary artery disease	7.07e-05	0.000366	CcSEcCtD
Guanfacine—Gastrointestinal pain—Timolol—coronary artery disease	7.05e-05	0.000365	CcSEcCtD
Guanfacine—Dizziness—Furosemide—coronary artery disease	7.05e-05	0.000365	CcSEcCtD
Guanfacine—Dyspepsia—Lisinopril—coronary artery disease	7.04e-05	0.000365	CcSEcCtD
Guanfacine—Diarrhoea—Losartan—coronary artery disease	7.04e-05	0.000364	CcSEcCtD
Guanfacine—Nausea—Trandolapril—coronary artery disease	7.02e-05	0.000364	CcSEcCtD
Guanfacine—Nausea—Enalapril—coronary artery disease	6.99e-05	0.000362	CcSEcCtD
Guanfacine—Vomiting—Perindopril—coronary artery disease	6.97e-05	0.000361	CcSEcCtD
Guanfacine—Abdominal pain—Ramipril—coronary artery disease	6.97e-05	0.000361	CcSEcCtD
Guanfacine—Decreased appetite—Lisinopril—coronary artery disease	6.95e-05	0.00036	CcSEcCtD
Guanfacine—Rash—Perindopril—coronary artery disease	6.91e-05	0.000358	CcSEcCtD
Guanfacine—Dermatitis—Perindopril—coronary artery disease	6.91e-05	0.000358	CcSEcCtD
Guanfacine—Nausea—Telmisartan—coronary artery disease	6.9e-05	0.000357	CcSEcCtD
Guanfacine—Fatigue—Lisinopril—coronary artery disease	6.89e-05	0.000357	CcSEcCtD
Guanfacine—Headache—Perindopril—coronary artery disease	6.87e-05	0.000356	CcSEcCtD
Guanfacine—Constipation—Lisinopril—coronary artery disease	6.84e-05	0.000354	CcSEcCtD
Guanfacine—Abdominal pain—Timolol—coronary artery disease	6.81e-05	0.000353	CcSEcCtD
Guanfacine—Dizziness—Losartan—coronary artery disease	6.8e-05	0.000352	CcSEcCtD
Guanfacine—Vomiting—Furosemide—coronary artery disease	6.78e-05	0.000351	CcSEcCtD
Guanfacine—Rash—Furosemide—coronary artery disease	6.72e-05	0.000348	CcSEcCtD
Guanfacine—Dermatitis—Furosemide—coronary artery disease	6.71e-05	0.000348	CcSEcCtD
Guanfacine—Nausea—Captopril—coronary artery disease	6.71e-05	0.000347	CcSEcCtD
Guanfacine—Headache—Furosemide—coronary artery disease	6.68e-05	0.000346	CcSEcCtD
Guanfacine—Feeling abnormal—Lisinopril—coronary artery disease	6.59e-05	0.000341	CcSEcCtD
Guanfacine—Gastrointestinal pain—Lisinopril—coronary artery disease	6.54e-05	0.000339	CcSEcCtD
Guanfacine—Vomiting—Losartan—coronary artery disease	6.54e-05	0.000339	CcSEcCtD
Guanfacine—Nausea—Perindopril—coronary artery disease	6.51e-05	0.000337	CcSEcCtD
Guanfacine—Hypersensitivity—Ramipril—coronary artery disease	6.5e-05	0.000336	CcSEcCtD
Guanfacine—Rash—Losartan—coronary artery disease	6.48e-05	0.000336	CcSEcCtD
Guanfacine—Dermatitis—Losartan—coronary artery disease	6.48e-05	0.000335	CcSEcCtD
Guanfacine—Headache—Losartan—coronary artery disease	6.44e-05	0.000334	CcSEcCtD
Guanfacine—Hypersensitivity—Timolol—coronary artery disease	6.35e-05	0.000329	CcSEcCtD
Guanfacine—Nausea—Furosemide—coronary artery disease	6.33e-05	0.000328	CcSEcCtD
Guanfacine—Asthenia—Ramipril—coronary artery disease	6.33e-05	0.000328	CcSEcCtD
Guanfacine—Abdominal pain—Lisinopril—coronary artery disease	6.32e-05	0.000327	CcSEcCtD
Guanfacine—Pruritus—Ramipril—coronary artery disease	6.24e-05	0.000323	CcSEcCtD
Guanfacine—Asthenia—Timolol—coronary artery disease	6.18e-05	0.00032	CcSEcCtD
Guanfacine—Nausea—Losartan—coronary artery disease	6.11e-05	0.000316	CcSEcCtD
Guanfacine—Pruritus—Timolol—coronary artery disease	6.1e-05	0.000316	CcSEcCtD
Guanfacine—Diarrhoea—Ramipril—coronary artery disease	6.03e-05	0.000312	CcSEcCtD
Guanfacine—Diarrhoea—Timolol—coronary artery disease	5.9e-05	0.000305	CcSEcCtD
Guanfacine—Hypersensitivity—Lisinopril—coronary artery disease	5.89e-05	0.000305	CcSEcCtD
Guanfacine—Dizziness—Ramipril—coronary artery disease	5.83e-05	0.000302	CcSEcCtD
Guanfacine—Asthenia—Lisinopril—coronary artery disease	5.74e-05	0.000297	CcSEcCtD
Guanfacine—Dizziness—Timolol—coronary artery disease	5.7e-05	0.000295	CcSEcCtD
Guanfacine—Pruritus—Lisinopril—coronary artery disease	5.66e-05	0.000293	CcSEcCtD
Guanfacine—Vomiting—Ramipril—coronary artery disease	5.61e-05	0.00029	CcSEcCtD
Guanfacine—Rash—Ramipril—coronary artery disease	5.56e-05	0.000288	CcSEcCtD
Guanfacine—Dermatitis—Ramipril—coronary artery disease	5.55e-05	0.000288	CcSEcCtD
Guanfacine—Headache—Ramipril—coronary artery disease	5.52e-05	0.000286	CcSEcCtD
Guanfacine—Vomiting—Timolol—coronary artery disease	5.48e-05	0.000284	CcSEcCtD
Guanfacine—Diarrhoea—Lisinopril—coronary artery disease	5.47e-05	0.000283	CcSEcCtD
Guanfacine—Rash—Timolol—coronary artery disease	5.44e-05	0.000281	CcSEcCtD
Guanfacine—Dermatitis—Timolol—coronary artery disease	5.43e-05	0.000281	CcSEcCtD
Guanfacine—Headache—Timolol—coronary artery disease	5.4e-05	0.00028	CcSEcCtD
Guanfacine—Dizziness—Lisinopril—coronary artery disease	5.29e-05	0.000274	CcSEcCtD
Guanfacine—Nausea—Ramipril—coronary artery disease	5.24e-05	0.000271	CcSEcCtD
Guanfacine—Nausea—Timolol—coronary artery disease	5.12e-05	0.000265	CcSEcCtD
Guanfacine—Vomiting—Lisinopril—coronary artery disease	5.08e-05	0.000263	CcSEcCtD
Guanfacine—Rash—Lisinopril—coronary artery disease	5.04e-05	0.000261	CcSEcCtD
Guanfacine—Dermatitis—Lisinopril—coronary artery disease	5.04e-05	0.000261	CcSEcCtD
Guanfacine—Headache—Lisinopril—coronary artery disease	5.01e-05	0.000259	CcSEcCtD
Guanfacine—Nausea—Lisinopril—coronary artery disease	4.75e-05	0.000246	CcSEcCtD
Guanfacine—ADRA2A—Metabolism—LPL—coronary artery disease	6.13e-06	9.85e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—CCL2—coronary artery disease	6.11e-06	9.82e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—IL6R—coronary artery disease	6.09e-06	9.79e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—HTR2A—coronary artery disease	6.09e-06	9.79e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CXCL10—coronary artery disease	6.09e-06	9.78e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—C3—coronary artery disease	6.08e-06	9.77e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PLG—coronary artery disease	6.07e-06	9.76e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—SLC22A3—coronary artery disease	6.04e-06	9.71e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—GPX1—coronary artery disease	5.98e-06	9.61e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ARNTL—coronary artery disease	5.96e-06	9.57e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—HADH—coronary artery disease	5.96e-06	9.57e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—ADRB2—coronary artery disease	5.91e-06	9.5e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PSMB5—coronary artery disease	5.85e-06	9.4e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PSMA6—coronary artery disease	5.85e-06	9.4e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	5.84e-06	9.38e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PRKCE—coronary artery disease	5.84e-06	9.38e-05	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—JAK2—coronary artery disease	5.83e-06	9.37e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—CD36—coronary artery disease	5.82e-06	9.36e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—SOCS1—coronary artery disease	5.82e-06	9.35e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—S100B—coronary artery disease	5.81e-06	9.33e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—HIF1A—coronary artery disease	5.8e-06	9.32e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—AGT—coronary artery disease	5.78e-06	9.29e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—AKT1—coronary artery disease	5.75e-06	9.24e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PPP2CA—coronary artery disease	5.75e-06	9.24e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—SOCS3—coronary artery disease	5.75e-06	9.24e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CTGF—coronary artery disease	5.71e-06	9.18e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PLCB1—coronary artery disease	5.71e-06	9.17e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—KITLG—coronary artery disease	5.68e-06	9.13e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—TGFBR2—coronary artery disease	5.68e-06	9.13e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—APOE—coronary artery disease	5.66e-06	9.1e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—LEP—coronary artery disease	5.66e-06	9.1e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—HMGCR—coronary artery disease	5.66e-06	9.1e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GOT2—coronary artery disease	5.66e-06	9.1e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—APOA2—coronary artery disease	5.65e-06	9.07e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	5.65e-06	9.07e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GPX2—coronary artery disease	5.65e-06	9.07e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	5.6e-06	9e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—APOA1—coronary artery disease	5.6e-06	8.99e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—HK1—coronary artery disease	5.58e-06	8.96e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GPX4—coronary artery disease	5.58e-06	8.96e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ABCG5—coronary artery disease	5.58e-06	8.96e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—SULT1A1—coronary artery disease	5.58e-06	8.96e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—STAT5A—coronary artery disease	5.55e-06	8.92e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MMP3—coronary artery disease	5.55e-06	8.92e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—KDR—coronary artery disease	5.55e-06	8.91e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—ABCA1—coronary artery disease	5.53e-06	8.89e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—MTHFR—coronary artery disease	5.52e-06	8.87e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—HADHA—coronary artery disease	5.51e-06	8.86e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MAPK14—coronary artery disease	5.51e-06	8.85e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GSTA1—coronary artery disease	5.45e-06	8.75e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—ESR1—coronary artery disease	5.41e-06	8.69e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—LPA—coronary artery disease	5.39e-06	8.66e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—APOB—coronary artery disease	5.37e-06	8.62e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—GGT1—coronary artery disease	5.36e-06	8.61e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—GOT1—coronary artery disease	5.36e-06	8.61e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—PIK3CA—coronary artery disease	5.34e-06	8.58e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—F2—coronary artery disease	5.34e-06	8.58e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—FN1—coronary artery disease	5.34e-06	8.58e-05	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—CXCL8—coronary artery disease	5.32e-06	8.55e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IL6ST—coronary artery disease	5.32e-06	8.55e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—JAK2—coronary artery disease	5.29e-06	8.51e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—EDN1—coronary artery disease	5.28e-06	8.49e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—NFKBIA—coronary artery disease	5.28e-06	8.48e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—AGT—coronary artery disease	5.24e-06	8.43e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CCL5—coronary artery disease	5.24e-06	8.42e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PLCB3—coronary artery disease	5.22e-06	8.38e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PLCB1—coronary artery disease	5.21e-06	8.36e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—APOA5—coronary artery disease	5.16e-06	8.3e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CSF2—coronary artery disease	5.16e-06	8.3e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—FGF1—coronary artery disease	5.16e-06	8.3e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—APOE—coronary artery disease	5.14e-06	8.26e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—LPL—coronary artery disease	5.12e-06	8.24e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—KIT—coronary artery disease	5.11e-06	8.21e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	5.11e-06	8.2e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MEF2C—coronary artery disease	5.08e-06	8.16e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—RPS6KB1—coronary artery disease	5.08e-06	8.16e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—APOA1—coronary artery disease	5.08e-06	8.16e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—P4HB—coronary artery disease	5.06e-06	8.14e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ABCA1—coronary artery disease	5.05e-06	8.11e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	4.97e-06	7.99e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—ITGB3—coronary artery disease	4.95e-06	7.95e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—GSK3B—coronary artery disease	4.9e-06	7.88e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GGT1—coronary artery disease	4.89e-06	7.85e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GOT1—coronary artery disease	4.89e-06	7.85e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—POMC—coronary artery disease	4.86e-06	7.82e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CREB1—coronary artery disease	4.86e-06	7.82e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—CXCL8—coronary artery disease	4.83e-06	7.77e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—GSTP1—coronary artery disease	4.81e-06	7.74e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PPP2CA—coronary artery disease	4.81e-06	7.73e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PPARGC1A—coronary artery disease	4.77e-06	7.66e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CCL2—coronary artery disease	4.76e-06	7.65e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—HMOX1—coronary artery disease	4.75e-06	7.63e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IL6R—coronary artery disease	4.74e-06	7.62e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PRKCD—coronary artery disease	4.72e-06	7.59e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—VCAN—coronary artery disease	4.69e-06	7.53e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CAT—coronary artery disease	4.68e-06	7.53e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IGF1—coronary artery disease	4.68e-06	7.52e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—MAPK1—coronary artery disease	4.66e-06	7.48e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ALDOA—coronary artery disease	4.65e-06	7.47e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—HTR2A—coronary artery disease	4.62e-06	7.43e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—C3—coronary artery disease	4.61e-06	7.41e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—APOB—coronary artery disease	4.55e-06	7.31e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—DCN—coronary artery disease	4.51e-06	7.25e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PPARG—coronary artery disease	4.47e-06	7.19e-05	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—PIK3CA—coronary artery disease	4.45e-06	7.15e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—SERPINE1—coronary artery disease	4.44e-06	7.14e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—GSTM1—coronary artery disease	4.42e-06	7.11e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—POMC—coronary artery disease	4.41e-06	7.09e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—HIF1A—coronary artery disease	4.4e-06	7.07e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ALDH2—coronary artery disease	4.39e-06	7.06e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GSTP1—coronary artery disease	4.39e-06	7.05e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—AGT—coronary artery disease	4.38e-06	7.05e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—AKT1—coronary artery disease	4.36e-06	7.01e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	4.35e-06	6.99e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—LPL—coronary artery disease	4.34e-06	6.98e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—HMOX1—coronary artery disease	4.33e-06	6.96e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—FGF2—coronary artery disease	4.3e-06	6.91e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—LEP—coronary artery disease	4.3e-06	6.9e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—APOE—coronary artery disease	4.3e-06	6.9e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CYP2C19—coronary artery disease	4.28e-06	6.88e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—HBA1—coronary artery disease	4.28e-06	6.88e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—LIPC—coronary artery disease	4.28e-06	6.88e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	4.28e-06	6.88e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CAT—coronary artery disease	4.27e-06	6.86e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—APOC3—coronary artery disease	4.25e-06	6.83e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—APOA1—coronary artery disease	4.25e-06	6.82e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—NOS3—coronary artery disease	4.24e-06	6.82e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—GPX1—coronary artery disease	4.24e-06	6.81e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—LDLR—coronary artery disease	4.23e-06	6.79e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—KDR—coronary artery disease	4.21e-06	6.76e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MAPK14—coronary artery disease	4.18e-06	6.72e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GSTT1—coronary artery disease	4.18e-06	6.71e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—SLC9A1—coronary artery disease	4.18e-06	6.71e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—APOB—coronary artery disease	4.15e-06	6.66e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GCLC—coronary artery disease	4.13e-06	6.63e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CETP—coronary artery disease	4.13e-06	6.63e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CD36—coronary artery disease	4.13e-06	6.63e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—JAK2—coronary artery disease	4.12e-06	6.62e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—ESR1—coronary artery disease	4.1e-06	6.59e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—SDC1—coronary artery disease	4.08e-06	6.56e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PPP2CA—coronary artery disease	4.07e-06	6.55e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—F2—coronary artery disease	4.05e-06	6.51e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—FN1—coronary artery disease	4.05e-06	6.51e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—PIK3CA—coronary artery disease	4.04e-06	6.49e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IL6ST—coronary artery disease	4.03e-06	6.48e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GSTM1—coronary artery disease	4.03e-06	6.48e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—ALB—coronary artery disease	4.02e-06	6.47e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NFKBIA—coronary artery disease	4e-06	6.43e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—LPL—coronary artery disease	3.96e-06	6.36e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—MTHFR—coronary artery disease	3.91e-06	6.28e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—KIT—coronary artery disease	3.88e-06	6.23e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GPX1—coronary artery disease	3.86e-06	6.21e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PSMA6—coronary artery disease	3.86e-06	6.2e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PSMB5—coronary artery disease	3.86e-06	6.2e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—NOS3—coronary artery disease	3.85e-06	6.18e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CTGF—coronary artery disease	3.77e-06	6.05e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CXCL8—coronary artery disease	3.76e-06	6.05e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CD36—coronary artery disease	3.76e-06	6.04e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—HMGCR—coronary artery disease	3.73e-06	6e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GOT2—coronary artery disease	3.73e-06	6e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—GSK3B—coronary artery disease	3.72e-06	5.98e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PPP2CA—coronary artery disease	3.71e-06	5.97e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—AGT—coronary artery disease	3.71e-06	5.97e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—POMC—coronary artery disease	3.69e-06	5.93e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CREB1—coronary artery disease	3.69e-06	5.93e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—APOE—coronary artery disease	3.64e-06	5.85e-05	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—AKT1—coronary artery disease	3.63e-06	5.84e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CCL2—coronary artery disease	3.61e-06	5.8e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CASP3—coronary artery disease	3.6e-06	5.79e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IL6R—coronary artery disease	3.6e-06	5.78e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—APOA1—coronary artery disease	3.6e-06	5.78e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—IL6—coronary artery disease	3.58e-06	5.75e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—MTHFR—coronary artery disease	3.56e-06	5.73e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IGF1—coronary artery disease	3.55e-06	5.7e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—MAPK1—coronary artery disease	3.53e-06	5.68e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PTGS2—coronary artery disease	3.52e-06	5.66e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CCND1—coronary artery disease	3.51e-06	5.63e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	3.45e-06	5.54e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PLCB1—coronary artery disease	3.43e-06	5.52e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MMP9—coronary artery disease	3.4e-06	5.47e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—AGT—coronary artery disease	3.39e-06	5.44e-05	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—PIK3CA—coronary artery disease	3.38e-06	5.42e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—SERPINE1—coronary artery disease	3.37e-06	5.42e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ABCA1—coronary artery disease	3.33e-06	5.35e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—APOE—coronary artery disease	3.32e-06	5.33e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—AKT1—coronary artery disease	3.3e-06	5.3e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—APOA1—coronary artery disease	3.28e-06	5.27e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—FGF2—coronary artery disease	3.26e-06	5.24e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GOT1—coronary artery disease	3.22e-06	5.18e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GGT1—coronary artery disease	3.22e-06	5.18e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NOS3—coronary artery disease	3.22e-06	5.17e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PPARG—coronary artery disease	3.17e-06	5.09e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	3.14e-06	5.05e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—JAK2—coronary artery disease	3.13e-06	5.03e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—POMC—coronary artery disease	3.13e-06	5.02e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—PIK3CA—coronary artery disease	3.07e-06	4.93e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—VEGFA—coronary artery disease	3.06e-06	4.91e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GSTP1—coronary artery disease	2.89e-06	4.65e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PPARG—coronary artery disease	2.89e-06	4.65e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	2.87e-06	4.61e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—HMOX1—coronary artery disease	2.85e-06	4.59e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CXCL8—coronary artery disease	2.85e-06	4.59e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—POMC—coronary artery disease	2.85e-06	4.58e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—ALB—coronary artery disease	2.85e-06	4.58e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CAT—coronary artery disease	2.82e-06	4.53e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—TGFB1—coronary artery disease	2.8e-06	4.51e-05	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—AKT1—coronary artery disease	2.76e-06	4.43e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MAPK1—coronary artery disease	2.75e-06	4.42e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—APOB—coronary artery disease	2.73e-06	4.39e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CASP3—coronary artery disease	2.73e-06	4.39e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—NOS3—coronary artery disease	2.73e-06	4.38e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—IL6—coronary artery disease	2.71e-06	4.36e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GSTM1—coronary artery disease	2.66e-06	4.27e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CCND1—coronary artery disease	2.66e-06	4.27e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—LPL—coronary artery disease	2.61e-06	4.2e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ALB—coronary artery disease	2.6e-06	4.18e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MMP9—coronary artery disease	2.58e-06	4.15e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GPX1—coronary artery disease	2.55e-06	4.09e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—AKT1—coronary artery disease	2.5e-06	4.02e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PTGS2—coronary artery disease	2.49e-06	4.01e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—NOS3—coronary artery disease	2.49e-06	4e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CD36—coronary artery disease	2.48e-06	3.99e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PPP2CA—coronary artery disease	2.45e-06	3.94e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PIK3CA—coronary artery disease	2.39e-06	3.84e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—MTHFR—coronary artery disease	2.35e-06	3.78e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—VEGFA—coronary artery disease	2.32e-06	3.73e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PTGS2—coronary artery disease	2.27e-06	3.65e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—AGT—coronary artery disease	2.23e-06	3.59e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—APOE—coronary artery disease	2.19e-06	3.52e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PIK3CA—coronary artery disease	2.17e-06	3.48e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—APOA1—coronary artery disease	2.16e-06	3.48e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—TGFB1—coronary artery disease	2.13e-06	3.42e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IL6—coronary artery disease	2.11e-06	3.4e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MAPK1—coronary artery disease	2.09e-06	3.35e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—AKT1—coronary artery disease	1.95e-06	3.13e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PPARG—coronary artery disease	1.91e-06	3.06e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—POMC—coronary artery disease	1.88e-06	3.02e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PIK3CA—coronary artery disease	1.81e-06	2.91e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—AKT1—coronary artery disease	1.77e-06	2.84e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ALB—coronary artery disease	1.71e-06	2.75e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—NOS3—coronary artery disease	1.64e-06	2.63e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IL6—coronary artery disease	1.6e-06	2.58e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PIK3CA—coronary artery disease	1.53e-06	2.47e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.5e-06	2.41e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—AKT1—coronary artery disease	1.48e-06	2.38e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PIK3CA—coronary artery disease	1.4e-06	2.25e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—AKT1—coronary artery disease	1.25e-06	2.01e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—AKT1—coronary artery disease	1.14e-06	1.84e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PIK3CA—coronary artery disease	9.23e-07	1.48e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—AKT1—coronary artery disease	7.54e-07	1.21e-05	CbGpPWpGaD
